Quantum Biopharma (QNTM) Change in Intangibles (2021 - 2026)

Quantum Biopharma's (QNTM) quarterly Change in Intangibles came in at -$3.0 million in Q1 2026, down 5.79% year-on-year from -$3.1 million in Q1 2025, and down 234.76% quarter-over-quarter from -$884881.0 in Q3 2025.

Quantum Biopharma (QNTM) Change in Intangibles (2021 - 2026) Analysis & Trends

Quantum Biopharma has disclosed Change in Intangibles across 4 years of filings, most recently posting -$3.0 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.96 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.96 Mn
Mar 31, 2026 -2.96 Mn
Sep 30, 2025 -884,881.00
Sep 30, 2025 -884,881.00
Jun 30, 2025 -1.45 Mn
Jun 30, 2025 -1.45 Mn
Mar 31, 2025 -2.80 Mn
Mar 31, 2025 -2.80 Mn
Mar 31, 2022 -250,000.00
Mar 31, 2022 -250,000.00
Sep 30, 2021 47,890.00
Sep 30, 2021 47,890.00
Mar 31, 2021 500,000.00
Mar 31, 2021 500,000.00